Human GPRC5D Full Length Protein, Flag,His Tag (Detergent)

用户评价
货号-规格
价格
Qty.
GPD-H52D5-20ug
¥7350.00
GPD-H52D5-100ug
¥27300.00
GPD-H52D5-500ug
询价
合计0件 产品金额¥ 0

产品详情

  • 应用说明(Application)

    1. Immunization
    2. Affinity testing (SPR / BLI)
    3. Screening (ELISA)
  • 分子别名(Synonym)

    GPRC5D, G-protein coupled receptor family C group 5 member D

  • 表达区间及表达系统(Source)

    Detergent Human GPRC5D Full Length Protein, Flag,His Tag (GPD-H52D5) is expressed from human 293 cells (HEK293). It contains AA Tyr 2 - Cys 300 (Accession # Q9NZD1-2 ).

    Predicted N-terminus: Asp

    Request for sequence
  • 蛋白结构(Molecular Characterization)

    GPRC5D Structure

    This protein carries a flag tag at the N-terminus and a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 37.9 kDa.

    *The DDM/CHS buffer (Cat. No. DC-11) is sold separately and not included in protein, you can follow the link for product information.

    1. Structure

      Each full-length transmembrane protein is encapsulated by detergent micelle.

    2. Synthesis Process

      Through mild detergent micelle extraction, dedicated solubilization, and stringent affinity purification, we maximally retain the native transmembrane conformation of full-length transmembrane proteins throughout downstream purification. This workflow yields purified, detergent-solubilized proteins free of unrelated membrane impurities and exogenous scaffold proteins, with exceptional purity, accurate quantitation, and well-preserved biological activity—ideal for immunization, binding assays in antibody discovery and screening (ELISA) and affinity testing (SPR and BLI), etc.

  • 内毒素(Endotoxin)

    Less than 1.0 EU per μg by the LAL method / rFC method.

  • 纯度(Purity)

    >85% as determined by SDS-PAGE.

  • 制剂(Formulation)

    This product is not suitable for cell based experiments due to cytotoxicity of DDM.
    DDM and CHS are INDISPENSABLE to keep membrane protein soluble and active, under no circumstances should you remove DDM and CHS.
    DDM/CHS buffer (DC-11) is sold separately and not included in protein, and please contact us if you need the buffer.
    If glycerol is not compatible with your application, remove glycerol just before the immediate experiment, and NEVER store glycerol-free protein solution.

    Supplied as 0.2 μm filtered solution in 50 mM HEPES, 150 mM NaCl, DDM, CHS, pH7.5 with glycerol as protectant.

    Contact us for customized product form or formulation.

  • 运输(Shipping)

    This product is supplied and shipped with dry ice, please inquire the shipping cost.

  • 存储(Storage)

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. The product MUST be stored at -70°C or lower upon receipt;
    2. -70°C for 3 months under sterile conditions.
  • 质量管理控制体系(QMS)

    1. 质量管理体系(ISO, GMP)
    2. 质量优势
    3. 质控流程

推荐产品

数据展示

  • 活性(Bioactivity)-ELISA

     GPRC5D ELISA

    Immobilized Human GPRC5D Full Length Protein, Flag,His Tag (Cat. No. GPD-H52D5) at 1 μg/mL (100 μL/well) can bind Anti-GPRC5D Antibody, Human IgG4 with a linear range of 0.5-16 ng/mL (QC tested).

    Protocol
  •  GPRC5D ELISA

    Immobilized Human GPRC5D Full Length Protein, Flag,His Tag (Cat. No. GPD-H52D5) at 1 μg/mL, add Talquetamab and then add Biotinylated Human CD3E&CD3G Heterodimer Protein, His,Avitag&Tag Free (Cat. No. CDG-H82W3) at 5 μg/mL. Detection was performed using HRP-conjugated Streptavidin (Cat. No. STN-NH913) (Routinely tested).

    Protocol
  • 活性(Bioactivity)-SPR

     GPRC5D SPR

    Anti-GPRC5D Antibody, Human IgG4 captured on Protein A Chip can bind Human GPRC5D Full Length Protein, Flag,His Tag (Cat. No. GPD-H52D5) with an affinity constant of 57.7 nM as determined in a SPR assay (in presence of DDM and CHS) (Biacore 8K) (Routinely tested).

    Protocol

用户评价
发表评论

背景介绍

An orphan G protein-coupled receptor with highly restricted expression in malignant plasma cells and hard keratinized tissues (hair/nail). This profile mitigates off-tumor toxicity, establishing GPRC5D as a breakthrough target for bispecific antibodies and CAR-T therapies in relapsed/refractory multiple myeloma.

前沿进展

 
药物研发进展
  • 英文全称:

    G-protein coupled receptor family C group 5member D

  • 中文全称:

    G蛋白偶联受体家族C组5成员D

  • 种类:

  • 上市药物数量:

    1 详情

  • 临床药物数量:

    28 详情

  • 最高研发阶段:

    批准上市

联系我们
项目合作
查看更多项目
实验案例分析
查看更多案例分析
  • 产品基础信息
  • 产品详情
  • 推荐产品
  • 数据展示
  • 用户评价
  • 背景介绍